Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc.
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:00am, Monday, 12'th Aug 2024
LOS ANGELES , Aug. 12, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "the C
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
03:53pm, Saturday, 10'th Aug 2024
LOS ANGELES--(BUSINESS WIRE)--MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
Moderna Inc Investors Can Participate In Fraud Investigations With The Schall Law Firm
09:15pm, Friday, 09'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Moderna, Inc. (
Pomerantz Law Firm Announces the Filing of a Class Action Against Moderna, Inc. and Certain Officers – MRNA
08:30pm, Friday, 09'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA) and certain officers. T
Moderna Inc Investors Eligible To Join Fraud Investigations With The Schall Law Firm
04:00pm, Thursday, 08'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Moderna, Inc. (
Moderna Inc Investors Can Join Fraud Investigations With The Schall Law Firm
11:30pm, Wednesday, 07'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Moderna, Inc. (
Moderna Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm
04:00pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Moderna, Inc. (
3 Undervalued Stocks With Room to Rally Even Higher
03:05pm, Monday, 05'th Aug 2024
Last week's market plunge could be a great opportunity to put new money to work. It may be difficult to tell what stocks will be in for next.
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
11:13am, Monday, 05'th Aug 2024
Moderna stock, which lost 27% of its value over two days, tumbled again Monday on a rare downgrade amid uncertainty for its vaccines.
Cathie Wood Bought This Stock After Its 27% Drop. Should You?
04:15am, Sunday, 04'th Aug 2024
Famous investor Cathie Wood is known for scooping up great stocks when they're down. She focuses on the long-term picture rather than the company's near-term, temporary challenges.
Three-Stock Lunch: Boeing, Moderna and Micron
05:32pm, Friday, 02'nd Aug 2024
Scott Nations, president of Nations Indexes, joins CNBC's 'Power Lunch' to discuss three stocks: Boeing, Moderna, and Micron.
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
02:22pm, Friday, 02'nd Aug 2024
On Thursday, Moderna Inc MRNA lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines.
MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm
10:00am, Friday, 02'nd Aug 2024
LOS ANGELES , Aug. 2, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Moderna, Inc. ("Mode
Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut
09:00am, Friday, 02'nd Aug 2024
COVID-19 vaccine maker Moderna, Inc. MRNA fell over 21% on Thursday after the company reduced its revenue guidance for the year, citing a highly competitive respiratory vaccine market in the U.S. and
